Rubens, J. A., Wang, S. Z., Price, A., Weingart, M. F., Allen, S. J., Orr, B. A., . . . Raabe, E. H. (2017). The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity. Neuro Oncol.

Rubens, Jeffrey A., Sabrina Z. Wang, Antoinette Price, Melanie F. Weingart, Sariah J. Allen, Brent A. Orr, Charles G. Eberhart, e Eric H. Raabe. "The TORC1/2 Inhibitor TAK228 Sensitizes Atypical Teratoid Rhabdoid Tumors to Cisplatin-induced Cytotoxicity." Neuro Oncol 2017.

Rubens, Jeffrey A., et al. "The TORC1/2 Inhibitor TAK228 Sensitizes Atypical Teratoid Rhabdoid Tumors to Cisplatin-induced Cytotoxicity." Neuro Oncol 2017.